Bisphosphonates: are they standard of care for the treatment of breast cancer?
Pritchard
K I
KI
D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004002:Clodronic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D050071:Bone Density Conservation Agents; D004002:Clodronic Acid; D019386:Alendronate